致心律失常性心肌病：一病、无病与十万种疾病
Arrhythmogenic Cardiomyopathy: One, None and a Hundred Thousand Diseases.
作者信息
Peretto Giovanni, Mazzone Patrizio
机构信息
Department of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
出版信息
J Pers Med. 2022 Jul 30;12(8):1256. doi: 10.3390/jpm12081256.
Abstract
According to the most recent expert consensus statement, arrhythmogenic cardiomyopathy (AC) is defined as an arrhythmogenic heart muscle disorder, not explained by ischemic, hypertensive, or valvular heart disease, presenting clinically as symptoms or documentation of atrial fibrillation, conduction disease, and/or right ventricular (RV) and/or left ventricular (LV) arrhythmia [...].
摘要
根据最新的专家共识声明，致心律失常性心肌病（AC）被定义为一种致心律失常性心肌疾病，不能用缺血性、高血压性或瓣膜性心脏病来解释，临床上表现为心房颤动、传导疾病和/或右心室（RV）和/或左心室（LV）心律失常的症状或记录[...]。
相似文献
1
Arrhythmogenic Cardiomyopathy: One, None and a Hundred Thousand Diseases.致心律失常性心肌病：一病、无病与十万种疾病
J Pers Med. 2022 Jul 30;12(8):1256. doi: 10.3390/jpm12081256.
2
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.2019 HRS 专家共识声明：致心律失常性右室心肌病的评估、危险分层与管理——执行摘要。
Heart Rhythm. 2019 Nov;16(11):e373-e407. doi: 10.1016/j.hrthm.2019.09.019.
3
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.2019 HRS 专家共识声明：心律失常性心肌病的评估、风险分层和管理。
Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.
4
Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病左侧基质的特征
Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1403-12. doi: 10.1161/CIRCEP.115.003213. Epub 2015 Aug 26.
5
Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.致心律失常性右室心肌病/发育不良中心律失常的发生率。
Heart Rhythm. 2013 Nov;10(11):1661-8. doi: 10.1016/j.hrthm.2013.08.032. Epub 2013 Aug 28.
6
MRI Findings in Desmoplakin-related Arrhythmogenic Left Ventricular Cardiomyopathy in a Pediatric Patient: A Case Report.一名儿科患者中桥粒斑蛋白相关致心律失常性左心室心肌病的MRI表现：病例报告
Radiol Cardiothorac Imaging. 2023 Mar 2;5(2):e220209. doi: 10.1148/ryct.220209. eCollection 2023 Apr.
7
Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.2015 年国际工作组共识声明风险分层算法在致心律失常性右室心肌病/发育不良中的植入式心脏复律除颤器放置中的表现。
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e005593. doi: 10.1161/CIRCEP.117.005593. Epub 2018 Feb 16.
8
[Arrhythmogenic right ventricular cardiomyopathy associated with arrhythmia-induced cardiomyopathy: A case report].[致心律失常性右室心肌病合并心律失常性心肌病：一例报告]
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Oct 18;53(5):1002-1006. doi: 10.19723/j.issn.1671-167X.2021.05.032.
9
Utilization of sacubitril-valsartan for right ventricular failure in a patient with arrhythmogenic right ventricular cardiomyopathy.沙库巴曲缬沙坦在心律失常性右室心肌病患者右心衰竭中的应用。
Future Cardiol. 2022 Jul;18(7):547-552. doi: 10.2217/fca-2021-0148. Epub 2022 Jun 15.
10
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.致心律失常性心肌病的拟议诊断标准：欧洲工作组共识报告。
Int J Cardiol. 2024 Jan 15;395:131447. doi: 10.1016/j.ijcard.2023.131447. Epub 2023 Oct 14.
引用本文的文献
1
Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench.心肌炎症作为遗传性心肌病的一种表现：从床边到实验室。
Biomolecules. 2023 Apr 4;13(4):646. doi: 10.3390/biom13040646.
本文引用的文献
1
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.氟代脱氧葡萄糖正电子发射断层扫描在心律失常性心肌炎中的临床应用
JACC Cardiovasc Imaging. 2022 Oct;15(10):1771-1780. doi: 10.1016/j.jcmg.2022.02.029. Epub 2022 May 11.
2
Boosting Bipolar Radiofrequency Energy Deployment to Target Deep Intramural Substrates.增强双极射频能量部署以靶向深层壁内基质。
JACC Clin Electrophysiol. 2022 Apr;8(4):511-512. doi: 10.1016/j.jacep.2022.02.005.
3
Autoimmune Myocarditis and Arrhythmogenic Mitral Valve Prolapse: An Unexpected Overlap Syndrome.自身免疫性心肌炎与致心律失常性二尖瓣脱垂：一种意外的重叠综合征。
J Cardiovasc Dev Dis. 2021 Nov 6;8(11):151. doi: 10.3390/jcdd8110151.
4
Continuous Electrical Monitoring in Patients with Arrhythmic Myocarditis: Insights from a Referral Center.心律失常性心肌炎患者的连续心电监测：来自转诊中心的见解
J Clin Med. 2021 Nov 1;10(21):5142. doi: 10.3390/jcm10215142.
5
Iron deficiency in chronic myocarditis: Assessment and prognostic significance.慢性心肌炎中的缺铁：评估及预后意义
Eur J Intern Med. 2021 Jul;89:129-131. doi: 10.1016/j.ejim.2021.03.037. Epub 2021 Apr 21.
6
Arrhythmic risk stratification in left ventricular noncompaction.左心室心肌致密化不全的心律失常风险分层
J Cardiovasc Electrophysiol. 2021 Mar;32(3):755-757. doi: 10.1111/jce.14882. Epub 2021 Jan 23.
7
Immunosuppressive therapy in childhood-onset arrhythmogenic inflammatory cardiomyopathy.儿童起病致心律失常性炎性心肌病的免疫抑制治疗。
Pacing Clin Electrophysiol. 2021 Mar;44(3):552-556. doi: 10.1111/pace.14153. Epub 2021 Jan 18.
8
Lamin cardiomyopathy risk stratification: Authors' reply.层粘连蛋白心肌病风险分层：作者回复。
Europace. 2021 Mar 8;23(3):487-488. doi: 10.1093/europace/euaa374.
9
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias.免疫抑制治疗与伴有室性心律失常的心肌炎患者的风险分层
JACC Clin Electrophysiol. 2020 Oct;6(10):1221-1234. doi: 10.1016/j.jacep.2020.05.013. Epub 2020 Jun 24.
10
Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis.心肌炎患者消融后复发性室性心动过速的预测因素：炎症。
J Am Coll Cardiol. 2020 Oct 6;76(14):1644-1656. doi: 10.1016/j.jacc.2020.08.012.
Zotero 插件